MasterControl, a leading provider of quality management and manufacturing software solutions, today announced the appointment of Kelly Starman as Chief M...
Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Merck Life Science in India announced the signing of a Memorandum of Understanding (MoU) with Aragen Life Sciences, a leading provider of R&D a...
Angiex, a developer of Nuclear-Delivered Antibody-Drug Conjugate™ (ND-ADC) therapies for solid cancers, announced that patient dosing has begun for...
-Parse Biosciences, a leading provider of cost-effective and scalable solutions for single-cell sequencing, today announced an agreement with the Taiwane...
Agreement builds on and complements Daiichi Sankyo and Merck’s shared commitment to develop novel medicines for patients with cancer Daiichi Sanky...
Investment in Oxford Nanopore, innovators of a transformational new generation of sensing technology that today specialises in DNA/RNA sequencing &pou...
Primary endpoint reached in phase 2 study in which the mRNA immunotherapy candidate BNT111 is evaluated in combination with the PD-1 checkpoint inhibit...
Triastek Inc. ("Triastek"), a global leader in 3D printing pharmaceuticals, announced that it has entered into a research collaboration and platfor...
GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, announced today that the American Medical Assoc...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 29...
Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, provides an overview of advances supporting th...
Rona Therapeutics, a clinical stage pioneering platform company in nucleic acid drug research and development, today announced the completion of $35 Mill...
Shanghai Junshi Biosciences Co., a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercializati...
© 2024 Biopharma Boardroom. All Rights Reserved.
